Adjunct Faculty
Adjunct faculty typically have an academic or research appointment at another institution and contribute or collaborate with one or more School of Medicine faculty members or programs.
Adjunct rank detailsHelen Parise, ScD
Associate Professor AdjunctAbout
Research
Publications
2025
Expected Surgical Risk and the Risk of Stroke and Brain Injury After Transcatheter Aortic Valve Replacement: A Patient-Level Pooled Analysis
Messé S, Grubman D, Huerter M, Dwyer M, Zivadinov R, Pietras C, Nazif T, Moses J, Shah T, Gambone L, Tripathi R, Forrest J, Vora A, Parise H, Lansky A. Expected Surgical Risk and the Risk of Stroke and Brain Injury After Transcatheter Aortic Valve Replacement: A Patient-Level Pooled Analysis. Journal Of The Society For Cardiovascular Angiography & Interventions 2025, 4: 103867. DOI: 10.1016/j.jscai.2025.103867.Peer-Reviewed Original ResearchTranscatheter aortic valve replacementAortic valve replacementHigh-risk patientsDW-MRIPooled analysisAcute brain injuryDW-MRI measurementsSTS-PROMValve replacementRisk patientsClinical outcomesLesion volumePatient-level pooled analysisCognitive declineMyocardial infarctionTransfemoral transcatheter aortic valve replacementClinical events committeeDiffusion-weighted magnetic resonance imagingSurgical mortality riskRisk-stratify patientsBrain injuryRates of all-causeAcute kidney injuryTotal lesion volumeRisk of strokeSafety and Efficacy of Endovascular Treatment Modalities for Below-the-Knee Arterial Disease: A Systematic Review and Network Meta-analysis.
Tirziu D, Saleh A, Huang H, Akhlaghi N, Breen T, Parikh S, Rosenfield K, Armstrong E, Geraghty P, Brodmann M, Adams G, Snyder D, Zilinyi R, Altin S, Parise H, Lansky A. Safety and Efficacy of Endovascular Treatment Modalities for Below-the-Knee Arterial Disease: A Systematic Review and Network Meta-analysis. Journal Of Endovascular Therapy 2025, 15266028251344809. PMID: 40586349, DOI: 10.1177/15266028251344809.Peer-Reviewed Original ResearchChronic limb-threatening ischemiaNetwork Meta-AnalysisMeta-analysisOdds ratioSystematic reviewConfidence intervalsInfrapopliteal arterial diseasePreferred Reporting ItemsTreatment of infrapopliteal artery diseaseRandomized Controlled TrialsBelow-the-kneeRandom-effects modelSystematic literature searchArtery diseaseEndovascular treatment modalitiesMajor amputationPercutaneous transluminal angioplastyReporting ItemsReference interventionLimb-threatening ischemiaDrug-Coated BalloonEndovascular revascularizationPROSPERO databaseCochrane DatabaseTarget limbDays Alive Out of Hospital for Patients with Left Ventricular Dysfunction From the STICH Trial
Faridi K, Huang H, Parise H, Ahmad T, Mori M, Chung M, Yeh R, Petrie M, Panza J, Rouleau J, Dabrowski R, Velazquez E. Days Alive Out of Hospital for Patients with Left Ventricular Dysfunction From the STICH Trial. JACC Heart Failure 2025, 13: 867-869. PMID: 40335237, DOI: 10.1016/j.jchf.2025.02.019.Peer-Reviewed Original ResearchCoronary artery bypass surgery improves restricted mean survival time in patients with ischemic cardiomyopathy
Reinhardt S, Huang H, Parise H, Ahmad T, Velazquez E, Faridi K. Coronary artery bypass surgery improves restricted mean survival time in patients with ischemic cardiomyopathy. American Heart Journal Plus Cardiology Research And Practice 2025, 54: 100538. PMID: 40485767, PMCID: PMC12142554, DOI: 10.1016/j.ahjo.2025.100538.Peer-Reviewed Original ResearchCoronary Artery Bypass GraftingAll-Cause MortalityIschemic cardiomyopathyMean survival timeMedical therapyRestricted mean survival timeClinical trialsEndpoint of all-cause mortalityInternational multicenter randomized clinical trialSurvival timeCoronary artery bypass surgeryOptimal medical therapyMulticenter Randomized Clinical TrialBenefit of coronary artery bypass graftingEffect of coronary artery bypass graftingIschemic heart failureArtery bypass surgeryCox proportional hazards modelsArtery Bypass GraftingRandomized clinical trialsProportional hazards modelSurgical treatmentBypass surgeryHeart failureBypass GraftingEffect of Sodium-Glucose Cotransporter-2 Inhibitors on the Progression of Aortic Stenosis
Shah T, Zhang Z, Shah H, Fanaroff A, Nathan A, Parise H, Lutz J, Sugeng L, Bellumkonda L, Redfors B, Omerovic E, Petrie M, Vora A, Fiorilli P, Kobayashi T, Ahmad Y, Forrest J, Giri J, Herrmann H, Lansky A. Effect of Sodium-Glucose Cotransporter-2 Inhibitors on the Progression of Aortic Stenosis. JACC Cardiovascular Interventions 2025, 18: 738-748. PMID: 39985508, DOI: 10.1016/j.jcin.2024.11.036.Peer-Reviewed Original ResearchSodium-glucose cotransporter-2 inhibitorsCotransporter-2 inhibitorsAortic stenosisEffects of sodium-glucose cotransporter-2 inhibitorsProgression of aortic stenosisBaseline AS severityAssociated with slower progressionEchocardiographic follow-upRetrospective electronic medical record dataAortic valve sclerosisDisease-related morbidityChronic kidney diseaseSGLT2i usageRates of diabetesSevere ASAS severityEjection fractionFollow-upPrimary outcomeGt;1 yearKidney diseaseMedical record dataYale New Haven Health SystemPatientsObservational study
2024
Long-term outcomes of ischaemia with no obstructive coronary artery disease (INOCA): a systematic review and meta-analysis
Odanović N, Schwann A, Zhang Z, Kapadia S, Kunnirickal S, Parise H, Tirziu D, Ilic I, Lansky A, Pietras C, Shah S. Long-term outcomes of ischaemia with no obstructive coronary artery disease (INOCA): a systematic review and meta-analysis. Open Heart 2024, 11: e002852. PMID: 39353703, PMCID: PMC11448144, DOI: 10.1136/openhrt-2024-002852.Peer-Reviewed Original ResearchConceptsCoronary Vasomotor Disorders International Study GroupRate of MACEReduced coronary flow reserveCoronary flow reservePrognosis of patientsVasospastic anginaPatient yearsMyocardial infarctionPrimary outcomeIncidence of primary outcomeLong-term prognosis of patientsSystematic reviewMeta-analysisLong-term prognosisInternational Study GroupAdverse cardiovascular eventsLong-term outcomesImaging stress testsMeta-analysis of studiesRandom-effects modelWeb of ScienceINOCACardiovascular eventsFollow-upVasomotor disordersTCT-187 Effect of Sodium-Glucose Cotransporter-2 Inhibitors on the Progression of Aortic Stenosis
Shah T, Shah H, Zhang Z, Fanaroff A, Nathan A, Parise H, Lutz J, Sugeng L, Bellumkonda L, Redfors B, Omerovic E, Petrie M, Vora A, Fiorilli P, Kobayashi T, Ahmad Y, Forrest J, Giri J, Herrmann H, Lansky A. TCT-187 Effect of Sodium-Glucose Cotransporter-2 Inhibitors on the Progression of Aortic Stenosis. Journal Of The American College Of Cardiology 2024, 84: b10. DOI: 10.1016/j.jacc.2024.09.223.Peer-Reviewed Original ResearchTCT-574 Safety and Efficacy of Percutaneous Ventricular Assist Device Versus Intra-Aortic Balloon Pump Supported High-Risk Percutaneous Coronary Intervention (HRPCI)
Shah T, Holy C, Moses J, Parise H, Lemor A, O'Neill W, Lansky A. TCT-574 Safety and Efficacy of Percutaneous Ventricular Assist Device Versus Intra-Aortic Balloon Pump Supported High-Risk Percutaneous Coronary Intervention (HRPCI). Journal Of The American College Of Cardiology 2024, 84: b210. DOI: 10.1016/j.jacc.2024.09.683.Peer-Reviewed Original ResearchTCT-573 Illness Severity Among Patients Undergoing Percutaneous Ventricular Assist Device Versus Intra-Aortic Balloon Pump Supported High-Risk Percutaneous Coronary Intervention (HRPCI)
Shah T, Holy C, Moses J, Parise H, Lemor A, O'Neill W, Lansky A. TCT-573 Illness Severity Among Patients Undergoing Percutaneous Ventricular Assist Device Versus Intra-Aortic Balloon Pump Supported High-Risk Percutaneous Coronary Intervention (HRPCI). Journal Of The American College Of Cardiology 2024, 84: b209. DOI: 10.1016/j.jacc.2024.09.682.Peer-Reviewed Original ResearchTCT-575 Cost-Effectiveness Analysis of Percutaneous Ventricular Assist Devices vs Intra-Aortic Balloon Pump for High-Risk Percutaneous Coronary Intervention (HRPCI)
Shah T, Holy C, Moses J, Parise H, Lemor A, O'Neill W, Lansky A. TCT-575 Cost-Effectiveness Analysis of Percutaneous Ventricular Assist Devices vs Intra-Aortic Balloon Pump for High-Risk Percutaneous Coronary Intervention (HRPCI). Journal Of The American College Of Cardiology 2024, 84: b210. DOI: 10.1016/j.jacc.2024.09.684.Peer-Reviewed Original Research